Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH Trial.
Sign Up to like & getrecommendations! Published in 2021 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2021.1157
Abstract: Importance In patients treated with ω-3 fatty acids, it remains uncertain whether achieved levels of eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) are associated with cardiovascular outcomes. Objective To determine the association between plasma levels… read more here.
Keywords: acid; trial; cardiovascular outcomes; corn oil ... See more keywords
Body Weight Variability and Risk of Cardiovascular Outcomes and Death in the Context of Weight Loss Intervention Among Patients With Type 2 Diabetes
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.0055
Abstract: Key Points Question How does an intensive lifestyle intervention affect the association between variability in adiposity indices and cardiovascular outcomes and deaths among adults with type 2 diabetes? Findings In this cohort study of 3604… read more here.
Keywords: variability; type diabetes; intervention; weight loss ... See more keywords
Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment
Sign Up to like & getrecommendations! Published in 2018 at "ESC Heart Failure"
DOI: 10.1002/ehf2.12331
Abstract: Left atrium (LA) dilation is associated with adverse cardiovascular (CV) outcomes. Blood stasis, thrombus formation and atrial fibrillation may occur, especially in heart failure (HF) patients. It is not known whether preventive antithrombotic treatment may… read more here.
Keywords: antithrombotic treatment; heart; cardiovascular outcomes; heart failure ... See more keywords
Do adrenergic alpha‐antagonists increase the risk of poor cardiovascular outcomes? A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14012
Abstract: Due to concerns regarding neurohormonal activation and fluid retention, adrenergic alpha‐1 receptor antagonists (A1Bs) are generally avoided in the setting of heart disease, namely, symptomatic heart failure (HF) with reduced ejection fraction (HFrEF). However, this… read more here.
Keywords: meta analysis; adrenergic alpha; meta; heart ... See more keywords
Meta‐analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes
Sign Up to like & getrecommendations! Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14213
Abstract: Absolute treatment effects—i.e. numbers needed to treat (NNTs)—of novel antidiabetic drugs for cardiovascular outcomes have not been comprehensively evaluated. We aimed to perform a meta‐analysis of digitalized individual patient outcomes to display and compare absolute… read more here.
Keywords: novel antidiabetic; antidiabetic drugs; numbers needed; drugs cardiovascular ... See more keywords
The impact of exercise on physical function, cardiovascular outcomes and quality of life in chronic kidney disease patients: a systematic review
Sign Up to like & getrecommendations! Published in 2018 at "International Urology and Nephrology"
DOI: 10.1007/s11255-018-1790-4
Abstract: The prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) is increasing steadily. CKD does not only relate to morbidity and mortality but also has impact on quality of life, depression and malnutrition.… read more here.
Keywords: life; cardiovascular outcomes; disease; quality life ... See more keywords
Cardiovascular Outcomes in Systemic Lupus Erythematosus
Sign Up to like & getrecommendations! Published in 2022 at "Current Cardiology Reports"
DOI: 10.1007/s11886-021-01626-9
Abstract: Purpose of the Review To review cardiovascular outcomes (CVE) in systemic lupus erythematosus (SLE) that evolves over time. Recent Findings Inception cohorts now report long-term data, and large population registries add to our knowledge. Mortality… read more here.
Keywords: risk; cardiovascular outcomes; systemic lupus; lupus erythematosus ... See more keywords
Patient Diversity and Population Health-Related Cardiovascular Outcomes Associated with Warfarin Use in Atrial Fibrillation: An Analysis Using Administrative Claims Data
Sign Up to like & getrecommendations! Published in 2018 at "Advances in Therapy"
DOI: 10.1007/s12325-018-0782-1
Abstract: AbstractIntroductionAnticoagulants are effective for stroke prevention in atrial fibrillation (AF). Data on population health-related cardiovascular outcomes by race/ethnicity and gender are not well described. The aim was to assess the impact of patient diversity on… read more here.
Keywords: warfarin; cardiovascular outcomes; race ethnicity; population health ... See more keywords
Training cardiovascular outcomes researchers: A survey of mentees and mentors to identify critical training gaps and needs
Sign Up to like & getrecommendations! Published in 2018 at "American Heart Journal"
DOI: 10.1016/j.ahj.2017.07.022
Abstract: Background Many young investigators are interested in cardiovascular (CV) outcomes research; however, the current training experience of early investigators across the United States is uncertain. Methods From April to November 2014, we surveyed mentees and… read more here.
Keywords: research; cardiovascular outcomes; survey; training ... See more keywords
Valve hemodynamic deterioration and cardiovascular outcomes in TAVR: A report from the STS/ACC TVT Registry
Sign Up to like & getrecommendations! Published in 2018 at "American Heart Journal"
DOI: 10.1016/j.ahj.2017.09.005
Abstract: Background Recent reports of leaflet abnormalities (detected using advanced imaging) have raised questions regarding transcatheter aortic valve replacement (TAVR) durability. We sought to determine the incidence of valve hemodynamic deterioration (VHD) and its association with… read more here.
Keywords: valve hemodynamic; sts acc; aortic valve; cardiovascular outcomes ... See more keywords
Oral Antidiabetic Agents and Cardiovascular Outcomes.
Sign Up to like & getrecommendations! Published in 2018 at "Current problems in cardiology"
DOI: 10.1016/j.cpcardiol.2017.07.003
Abstract: Cardiovascular disease is the leading cause of morbidity and mortality among patients with type 2 diabetes; however, a direct protective effect of tight glycemic control remains unproven. In fact, until 2008, when concerns related to… read more here.
Keywords: antidiabetic agents; agents cardiovascular; oral antidiabetic; cardiovascular outcomes ... See more keywords